Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jun;72(6):3359-65.
doi: 10.1128/IAI.72.6.3359-3365.2004.

Cryptococcus neoformans capsule structure evolution in vitro and during murine infection

Affiliations

Cryptococcus neoformans capsule structure evolution in vitro and during murine infection

Dea Garcia-Hermoso et al. Infect Immun. 2004 Jun.

Abstract

Cryptococcus neoformans capsule structure modifications after prolonged in vitro growth or in vivo passaging have been reported previously. However, nothing is known about the dynamics of these modifications or about their environmental specificities. In this study, capsule structure modifications after mouse passaging and prolonged in vitro culturing were analyzed by flow cytometry using the glucuronoxylomannan-specific monoclonal antibody E1. The capsule structures of strains recovered after 0, 1, 8, and 35 days were compared by using the level of E1-specific epitope expression and its cell-to-cell heterogeneity within a given cell population. In vitro, according to these parameters, the diversity of the strains was higher on day 35 than it was initially, suggesting the absence of selection during in vitro culturing. In contrast, the diversity of the strains recovered from the brain tended to decrease over time, suggesting that selection of more adapted strains had occurred. The strains recovered on day 35 from the spleen and the lungs had different phenotypes than the strains isolated from the brain of the same mouse on the same day, thus strongly suggesting that there is organ specificity for C. neoformans strain selection. Fingerprinting of the strains recovered in vitro and in vivo over time confirmed that genotypes evolved very differently in vitro and in vivo, depending on the environment. Overall, our results suggest that organ-specific selection can occur during cryptococcosis.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Clinical isolate virulence assays. The survival of mice infected with 104 viable yeast cells from one of seven clinical isolates recovered from the same patient are shown.
FIG. 2.
FIG. 2.
Heterogeneity of the capsule structure within a clonal cell population. (A) Cells from strain C45a were grown on induction medium and labeled with the anti-GXM MAb E1. The arrows indicate strongly labeled cells (white arrows) and negative cells (black arrows). (B) FACS analysis of this cell population.
FIG. 3.
FIG. 3.
(A) Evolution of CENTEL hybridization patterns of strains isolated from the brain over time. Stars indicate profile changes compared to the original strain C45a (profile I). Roman numerals refer to the different profiles. (B) Schematic representation of the evolution of CENTEL hybridization patterns of strains isolated from continuous culture (▴) or from different organs (▪). B, brain; S, spleen; L, lungs. Roman numerals refer to the different profiles. Only two strains isolated from the lungs on day 8 gave interpretable profiles, and they are not included in this figure.
FIG. 4.
FIG. 4.
Capsule structure evolution as assessed by median fluorescence intensity (A) and heterogeneity of the cell population (CVF; see Materials and Methods) (B) after in vitro or in vivo passaging. Two in vivo independent experiments were done, one with a large inoculum (105 cells per mouse) and one with a small inoculum (104 cells per mouse).

Similar articles

Cited by

References

    1. Bose, I., A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2:655-663. - PMC - PubMed
    1. Brandt, M. E., C. Hutwagner, L. A. Klug, W. S. Baughman, D. Rimland, E. A. Graviss, R. J. Hamill, C. Thomas, P. G. Pappas, A. L. Reingold, R. W. Pinner, and the Cryptococcal Disease Active Surveillance Group. 1996. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J. Clin. Microbiol. 34:912-917. - PMC - PubMed
    1. Buchanan, K. L., and J. W. Murphy. 1998. What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4:71-83. - PMC - PubMed
    1. Cherniak, R., L. C. Morris, T. Belay, E. D. Spitzer, and A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1899-1905. - PMC - PubMed
    1. Cherniak, R., H. Valafar, L. C. Morris, and F. Valafar. 1998. Cryptococcus neoformans chemotyping by quantitative analysis 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab. Immunol. 5:146-159. - PMC - PubMed

Publication types

MeSH terms